Harold Cordner, MD
Interventional Pain Medicine · Sebastian, FLNPI 1487641924
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,198 of the $53,684 with a category attached, or 65.6%. Medtronic accounts for 67.6% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2022 at $13,032 and has fallen 97.7% since, to $304 in 2025. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 233 payments — averaging $230.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$36K
- Vertiflex, Inc.$9K
- Boston Scientific$2K
- Abbott$1K
- Relievant Medsystems, Inc.$1K
- Foundation Fusion Solutions, LLC$608
- plus $3K from 29 others
Across 12 payments — averaging $1247.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$10K
- Medtronic$3K
- Vertiflex, Inc.$1K
What the payments were for
- Consulting fees$3,7207%
- Speaking & faculty fees$35,19866%
- Travel & lodging$3,9407%
- Food & beverage$10,66920%
- Education$1240%
- Entertainment$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 48 | $36,292 |
| Vertiflex, Inc. | 22 | $8,983 |
| Boston Scientific | 37 | $1,796 |
| Abbott | 17 | $1,402 |
| Relievant Medsystems, Inc. | 9 | $1,119 |
| Foundation Fusion Solutions, LLC | 6 | $608 |
| Nevro Corp. | 16 | $571 |
| Captiva Spine Inc | 3 | $397 |
| Vertos Medical, Inc. | 6 | $380 |
| Curonix LLC | 3 | $330 |
| Neuronetics, Inc. | 2 | $216 |
| Painteq LLC | 2 | $214 |
| AbbVie(2 entities) | 9 | $183 |
| IBSA Pharma Inc. | 11 | $183 |
| Stimwave Technologies Incorporated | 6 | $171 |
| Collegium Pharmaceutical, Inc. | 10 | $169 |
| Protega Pharmaceutials Inc | 2 | $103 |
| Pfizer | 5 | $94 |
| Nalu Medical, Inc. | 2 | $74 |
| Spinal Simplicity, LLC | 2 | $48 |
| Averitas Pharma Inc. | 1 | $37 |
| Zavation Medical Products, LLC | 1 | $37 |
| Zimmer Biomet | 1 | $37 |
| Saluda Medical Americas, Inc. | 1 | $29 |
| Almatica Pharma LLC | 1 | $29 |
| SPR Therapeutics, Inc | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $23 |
| GRT US Holding, Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| AstraZeneca | 1 | $12 |
| Shionogi Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$15,733
- INTELLIS ADAPTIVESTIM$12,996
- Superion ISS$8,585
- Intracept$1,916
- VANTA ADAPTIVESTIM$1,575
- RESTORE$1,435
- Proclaim Family of SCS IPGs$554
- VECTRIS$410
- GENERAL PAIN MANAGEMENT$323
- Transfasten$314
- Proclaim IPG$293
- mild Device Kit$283
- SUPERION$245
- NEUROSTAR TMS THERAPY SYSTEM$216
- SPECIFY SURESCAN MRI 5-6-5$205
- PAINTEQ$192
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$142
- Senza Spinal Cord Stimulation System$132
- Eon Family of SCS IPGs$120
- Omnia$117
How this compares
$53,684 in reported general payments places this provider in the 90th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PercocetOxycodone Hcl/Acetaminophen | 11 | $44,223 |
| OxycontinOxycodone Hcl | 46 | $31,087 |
| MovantikNaloxegol Oxalate | 26 | $15,488 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 459 | $12,334 |
| Pregabalin | 175 | $9,901 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 311 | $9,198 |
| Fentanyl | 53 | $6,111 |
| Oxycodone Hcl | 215 | $4,656 |
| Gabapentin | 313 | $3,902 |
| Morphine Sulfate ErMorphine Sulfate | 83 | $2,645 |
| Tramadol Hcl | 282 | $2,520 |
| Morphine Sulfate | 62 | $1,994 |
| Buprenorphine Hcl | 32 | $1,755 |
| Buprenorphine | 12 | $1,367 |
| Tramadol Hcl ErTramadol Hcl | 13 | $1,145 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Sebastian
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.